Try our beta test site
7 studies found for:    "methodist hospital" | Open Studies | "Heart Valve Diseases" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting Effect of MitraClip on Acute and Chronic Reverse Cardiac Remodeling Assessed by CMR: The MITRA-REVERSE Study
Condition: Mitral Regurgitation
Interventions: Diagnostic Test: Cardiac MRI;   Diagnostic Test: Blood sample
2 Recruiting Medtronic Transcatheter Aortic Valve Replacement in Low Risk Patients
Condition: Aortic Valve Stenosis
Interventions: Device: Medtronic Transcatheter Aortic Valve Replacement Systems;   Device: Surgical Aortic Valve Replacement (SAVR)
3 Recruiting Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial)
Conditions: Mitral Regurgitation;   Mitral Valve Regurgitation
Intervention: Device: MitraClip System
4 Recruiting PERIGON Pivotal Trial
Condition: Aortic Stenosis
Intervention: Device: Model 400 aortic valve bioprosthesis
5 Recruiting Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Condition: Aortic Valve Stenosis
Interventions: Device: Portico transcatheter aortic valve;   Device: Commercially available transcatheter aortic valve
6 Recruiting The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation
Condition: Symptomatic Aortic Stenosis
Interventions: Device: Embolic Protection Device;   Procedure: Transcatheter aortic valve implantation (TAVI)
7 Recruiting Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
Condition: Severe Aortic Stenosis
Interventions: Device: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI);   Procedure: Surgical Aortic Valve Replacement (SAVR) (Not applicable for Single Arm);   Device: Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)

Study has passed its completion date and status has not been verified in more than two years.